4.7 Article

Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0

Wolfgang P. Fendler et al.

Summary: This article aims to provide updated guidance and standards for the use of PSMA PET/CT in imaging prostate cancer. It discusses procedures and characteristics of various PSMA small radioligands and different clinical scenarios for their use. The document is intended to support clinicians and technicians in implementing PSMA PET/CT imaging in both research and routine practice.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

Article Urology & Nephrology

Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery

Sophie Knipper et al.

Summary: This study evaluated the oncological outcomes of salvage PSMA-RGS in patients with recurrent oligometastatic prostate cancer and identified predictive preoperative factors for improved outcomes. The results showed that the 3-month and 2-year tumor survival rates were 32% and 58%, respectively. Preoperative PSA, number of PSMA-avid lesions, and localization of lesions were independent predictors of biochemical recurrence after PSMA-RGS.

EUROPEAN UROLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Quantifying the Impact of Signal-to-background Ratios on Surgical Discrimination of Fluorescent Lesions

Samaneh Azargoshasb et al.

Summary: This study investigates the impact of signal-to-background ratios (SBR) on surgical performance using kinematics analysis. The results show that below SBR 1.5, task completion time, time spent in fluorescence-imaging mode, and total pathlength increase significantly, and handling errors become more frequent. The values of Dx and DM indicate that proficiency can only be achieved at SBR> 1.55.

MOLECULAR IMAGING AND BIOLOGY (2023)

Article Oncology

First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial

Judith A. Stibbe et al.

Summary: This study assessed the safety and feasibility of PSMA-targeted fluorescent tracer OTL78 in patients with prostate cancer. The results showed that OTL78 was well tolerated and had the potential to improve prostate cancer detection. The optimal dosing was 0.03 mg/kg, administered 24 hours before surgery.

LANCET ONCOLOGY (2023)

Review Urology & Nephrology

State of the Art in Prostate-specific Membrane Antigen-targeted Surgery-A Systematic Review

Anne-Claire Berrens et al.

Summary: PSMA-targeted surgery helps identify and remove malignant tissue in prostate cancer patients while preserving adjacent structures. Most studies on PSMA-targeted surgery are pilot studies with short follow-up periods.

EUROPEAN UROLOGY OPEN SCIENCE (2023)

Article Automation & Control Systems

Artificial Intelligence-Supported Video Analysis as a Means to Assess the Impact of DROP-IN Image Guidance on Robotic Surgeons: Radioguided Sentinel Lymph Node versus PSMA-Targeted Prostate Cancer Surgery

Samaneh Azargoshasb et al.

Summary: The tethered DROP-IN gamma probe enables targeted robot-assisted radioguided prostate cancer resection. PSMA-targeted resections result in significantly lower signal intensities, which can affect the surgical decision-making process.

ADVANCED INTELLIGENT SYSTEMS (2023)

Article Urology & Nephrology

Robot-assisted Prostate-specific Membrane Antigen-radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study

Hilda A. de Barros et al.

Summary: The study shows that robot-assisted minimally invasive surgery combined with PSMA-radioguidance is effective in resecting PSMA-avid lesions, offering potential benefits for the treatment of patients with prostate cancer.

EUROPEAN UROLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer

William Gondoputro et al.

Summary: The safety and feasibility of robot-assisted 99mTc-based PSMA-radioguided surgery for the intraoperative detection of lymph node metastases were evaluated. The results showed that this surgical method can improve lymph node detection and has a certain degree of accuracy.

JOURNAL OF NUCLEAR MEDICINE (2022)

Article Urology & Nephrology

Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study

Giorgio Gandaglia et al.

Summary: This study reported the use of prostate-specific membrane antigen radioguided surgery for the identification of lymph node invasion during robot-assisted radical prostatectomy. The results showed that this method had high specificity and good safety in intraoperative identification of lymph node metastasis in patients with cN0cM0 prostate cancer, but had limitations in sensitivity.

EUROPEAN UROLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

Stefano Fanti et al.

Summary: PSMA PET/CT can be used to evaluate treatment response in patients with metastatic prostate cancer before and after any local and systemic treatment. Ideally, imaging criteria should categorize patients as responders, patients with stable disease, partial response, and complete response, or as non-responders. Specific clinical scenarios deserve special consideration.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Occupational Radiation Exposure of Radiopharmacy, Nuclear Medicine, and Surgical Personnel During Use of [99mTc]Tc-PSMA-I&S for Prostate Cancer Surgery

Else A. Aalbersberg et al.

Summary: This study aimed to estimate and measure occupational radiation exposure for personnel involved in procedures with [Tc-99m]Tc-PSMA-I&S. Results indicated that the effective dose for individuals during a single procedure ranged from 0 to 5 mu Sv, suggesting that it is safe for imaging and radioguided surgery.

JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY (2021)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging

Ann-Christin Eder et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Urology & Nephrology

Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy

Sophie Knipper et al.

Summary: A retrospective study evaluated 40 patients with local recurrence who underwent salvage surgery, finding that surgery may prolong treatment-free survival in selected cases.

EUROPEAN UROLOGY (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Review of commonly used prostate specific PET tracers used in prostate cancer imaging in current clinical practice

Muhammad Junaid Niaz et al.

Summary: This article discusses the advantages and limitations of PET imaging tracers Ga-68/F-18 PSMA, C-11-Choline, and F-18-fluciclovine for prostate cancer. PSMA PET shows higher sensitivity in detecting primary and recurrent cancer, influencing treatment planning by improving disease delineation.

CLINICAL IMAGING (2021)

Review Urology & Nephrology

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Nicolas Mottet et al.

Summary: The 2020 EAU-EANM-ESTRO-ESUR-SIOG guidelines on screening, diagnosis, and treatment of localized prostate cancer summarize the most recent recommendations for clinical practice, including risk-adapted strategies, medical imaging utilization, biopsy techniques, patient classification, and treatment options. Recommendations include consideration of moderate hypofractionation for intermediate-risk patients and a combination of local treatment with long-term hormonal therapy for cN1 PCa patients.

EUROPEAN UROLOGY (2021)

Article Oncology

Small Molecule, Multimodal, [18F]-PET and Fluorescence Imaging Agent Targeting Prostate-Specific Membrane Antigen: First-in-Human Study

Omer Aras et al.

Summary: The study conducted a first-in-human study of [F-18]-BF3-Cy3-ACUPA in patients with PSMA+ tumors, demonstrating that the imaging agent is safe and feasible in humans for tumor detection both preoperatively and intraoperatively.

CLINICAL GENITOURINARY CANCER (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

How molecular imaging will enable robotic precision surgery The role of artificial intelligence, augmented reality, and navigation

Thomas Wendler et al.

Summary: Molecular imaging plays a crucial role in precision surgery, covering early diagnostics, treatment planning, and outcome evaluation. The rapid development of surgical medical devices is bridging technology and surgical processes, creating a promising future for the molecular imaging and surgery communities.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Review Automation & Control Systems

Intelligent Soft Surgical Robots for Next-Generation Minimally Invasive Surgery

Jiaqi Zhu et al.

Summary: Minimally invasive surgery (MIS) is one of the most rapidly developing areas in modern surgery, with soft robotics offering better adaptability and safer interaction. The intelligent development of next-generation soft surgical robots holds great promise in addressing current technical challenges in MIS and providing a propitious solution for future surgery.

ADVANCED INTELLIGENT SYSTEMS (2021)

Article Surgery

Multi-wavelength fluorescence imaging with a da Vinci Firefly-a technical look behind the scenes

Philippa Meershoek et al.

Summary: The field of fluorescence-guided surgery is advancing with the use of different colored fluorescent tracers to visualize various anatomical structures in the same patient. Research shows that clinical-grade fluorescence laparoscopes can achieve multi-wavelength fluorescence imaging, with critical factors including dye properties, imaging system performance, and dye accumulation. The Xi camera system exhibited more effective excitation and higher detection sensitivity for both Fluorescein and ICG, indicating progress towards routine implementation of multi-wavelength image-guided surgery concepts.

JOURNAL OF ROBOTIC SURGERY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Intraoperative 68Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility Study

Christopher Darr et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-PSMA Cerenkov luminescence imaging in primary prostate cancer: first-in-man series

Judith Olde Heuvel et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

A DROP-IN beta probe for robot-assisted 68Ga-PSMA radioguided surgery: first ex vivo technology evaluation using prostate cancer specimens

Francesco Collamati et al.

EJNMMI RESEARCH (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer

Stephanie Robu et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

Article Urology & Nephrology

Sentinel node biopsy for prostate cancer: report from a consensus panel meeting

Henk G. van der Poel et al.

BJU INTERNATIONAL (2017)

Review Radiology, Nuclear Medicine & Medical Imaging

Cerenkov luminescence imaging: physics principles and potential applications in biomedical sciences

Esther Ciarrocchi et al.

EJNMMI PHYSICS (2017)

Editorial Material Oncology

Surgical Guidance in Prostate Cancer: From Molecule to Man Translations

Fijs W. B. van Leeuwen et al.

CLINICAL CANCER RESEARCH (2016)

Article Medicine, General & Internal

IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages

Patrick L. Ergina et al.

BMJ-BRITISH MEDICAL JOURNAL (2013)